KORU Medical Q3 revenue rises 11% year-over-year
KRMD•KORU Medical's third-quarter revenue rose 11% year-over-year to $11.6 million, and it reported $218,000 in net income. The company raised its 2026 revenue guidance to $48.0 million-$48.5 million and expects gross margin of 63%-64%.
1. Quarterly results
KORU Medical reported third-quarter revenue of $11.6 million, up 11% year-over-year, and net income of $218,000. Gross margin was 65.2%, and operating expenses were $7.36 million. The company posted its second consecutive quarter of positive net income and adjusted EBITDA.
2. Raised 2026 outlook
The company raised its full-year 2026 revenue guidance to $48.0 million-$48.5 million from $47.5 million-$48.5 million. It now expects 2026 gross margin of 63%-64%, compared with its prior range of 62%-64%, and forecasts a year-end cash balance above $8.0 million.
3. Revenue drivers
Higher pump and consumable volumes, new patient starts, and market-share gains drove domestic revenue growth. Gross margin increased due to lower manufacturing costs, favorable customer mix, and tariff rebates. International revenue declined against a strong prior-year comparison, partly offset by new patient starts.
